พบ "Public health policy"ทั้งหมด 1,265 ผลลัพธ์
เรียงลำดับตาม
ฮ - ก

Towards A Sustainable Kidney Replacement Therapy Program: Recommendations for Thailand’s 2022 Dialysis Reform

The National Health Security Office Working Group (NHSO WG) conducted structured, evidence-based deliberations to generate recommendations for the National Health Security Board on the kidney replacement therapy (KRT) policy. These are the proposed recommendations: To consider defining KRT p

Too Much Medical Care?

A few years ago, my daughter sprained her ankle at dance camp. What happened next offers a glimpse into some of the problems in our nation’s health care system.For years, we’ve been hearing that the United States spends more on health care than any other country, even as it lags far behind other cou

To include or not include: renal dialysis policy in the era of universal health coverage

SUMMARY POINTS •  End stage renal disease (ESRD) is a life-threatening condition that results in most patients requiring a lifetime of high cost renal dialysis •  Governments have grappled with the political, economic, and ethical challenges of providing treatment with their available budgets •

The way home: a scoping review of public health interventions to increase the utilization of home dialysis in chronic kidney disease patients

Abstract Background Home dialysis (HoD) remains underutilized, despite evidence showing it provides comparable mortality rates to in-center hemodialysis (ICHD) while offering advantages such as improved quality of life and lower overall costs. This scoping review comprehensively evaluates the

The use of economicevaluation for guiding the pharmaceutical reimbursement list in Thailand. (2014)

Summary Medicines expenditure consumes a significant proportion of public health expenditure in Thailand, where Universal Health Coverage has been in place since 2002. The National List of Essential Medicines has been successfully used as a pharmaceutical benefits package for all public health plan

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit package

Abstract: There is increasing impetus to use pharmaceutical interventions, ie, ranibizumab or bevacizumab, for the treatment of particular macular diseases. This paper describes the evidence and decision-making of the National List of Essential Medicines Committee that recently announced the inclusi

The Trouble With ‘Doctor Knows Best’

Doctors were told last month that we should stop doing so many screenings for prostate cancer with the prostate-specific antigen test. We learned that sigmoidoscopy is a cheaper, easier and effective alternative to colonoscopy for colon cancer screening. And a study I led turned up strong evidence t

The socio-economic impact of anti-microbial resistance in Singapore: A One Health perspective

Antimicrobial resistance (AMR) will continue to significantly impact healthcare and public health around the world. Given the complexity of AMR and the multi-dimensional nature of its aetiology and impact, a multi-sectoral and inter-disciplinary approach is required to mitigate its impact. “One Health” is an approach to designing and implementi

The role of health technology assessment evidence in decision making: the case of Human Papillomavirus vaccination

HPV vaccination policy in Thailand had been largely driven by the unaffordable prices of vaccine products. Although domestic HTA in formation, including health economic data of intervention, had been available, such evidence play a limited role in HPV vaccination policy formulation. Existing cost-effectiveness studies have resulted in efforts to im
10 / หน้า